SAM #75N98026Q00977

NIH Solicitation for Custom HuCAL Recombinant Fab Antibody for Retinitis Pigmentosa Research

The National Institutes of Health (NIH), Office of the Director, Office of Logistics and Multiple Acquisition Operations, is seeking to procure a custom HuCAL recombinant Fab antibody for in vitro research supporting the Therapeutics for Retinitis Pigmentosa PEDF project by NCATS. - Government Buyer: - National Institutes of Health (NIH), Office of the Director, Office of Logistics and Multiple Acquisition Operations - OEMs and Vendors: - Bio-Rad AbD Serotec GmbH (OEM/manufacturer of HuCAL technology) - Products/Services Requested: - Custom HuCAL recombinant Fab antibody (Part Number: AbD57571pao) - Quantity: 1 lot (2.8 mg) - Features: DYKDDDDK, Spy2, and His-6 tags; coupled Fab antibody format using SpyTag/SpyCatcher technology; specific for a 17-amino-acid peptide from PEDF protein; affinity purified; ELISA tested for functionality and specificity; for in vitro research - Unique/Notable Requirements: - Antibody must be custom-generated using proprietary HuCAL technology - No commercially available equivalent accepted - Delivery required within 5 to 7 weeks after order acceptance - Intended for specialized research use in the PEDF project

Description

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes only solicitation; proposals are being requested, and a separate written solicitation will not be issued.(ii) The solicitation number is 75N98026Q00977. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold (if applicable).The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a (Firm-Fixed-Price) to the offeror responsible whose proposal represents the best value to the Government.(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular effective August 7, 2026(iv) The associated NAICS code is 325414 Biological Product (except Diagnostic) Manufacturing, and the small business size standard is 1250 Employees.This requirement is unrestricted.

View original listing